Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -50.25% vs 52.27% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -400.00% vs 53.45% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -3,833.33% vs 107.69% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 2.38% vs 200.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Aquestive Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 14.94% vs -26.89% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -50.25% vs 52.27% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 41.05% vs -33.92% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -400.00% vs 53.45% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 41.67% vs -43.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -3,833.33% vs 107.69% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 2.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2.38% vs 200.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






